Sutro Biopharma, Inc. (STRO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -42.26M | -26.43M | -38.19M | -44.72M | -67.88M | -71.74M | -64.52M | 9.46M | -64.74M | 14.07M | -33.5M | -31.2M |
| Operating CF Margin % | -290.98% | -226.97% | -393.99% | -70.16% | -390.15% | -484.42% | -757.23% | 36.78% | -497.7% | 12.37% | -197.96% | -299.61% |
| Operating CF Growth % | 37.75% | 63.15% | 40.81% | -573.02% | -4.85% | -609.79% | -92.57% | 130.31% | -6.15% | 158.97% | -150.87% | -879.13% |
| Net Income | -38.48M | -46.76M | -56.86M | -11.5M | -75.97M | -72.44M | -48.79M | -48.02M | -58.21M | 31.07M | -49.28M | -38.52M |
| Depreciation & Amortization | 0 | 1.62M | 1.9M | 1.9M | 1.9M | 1.87M | 1.8M | 1.79M | 1.76M | 1.73M | 1.74M | 1.73M |
| Stock-Based Compensation | 0 | 1.66M | 1.55M | 5.26M | 5.54M | 5.92M | 6.54M | 6.16M | 6.07M | 6.22M | 0 | 6.66M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.16M |
| Other Non-Cash Items | 13.17M | 12.37M | 10.57M | 10.19M | 9.79M | 8.66M | -16.95M | 1.15M | 2.26M | -3.37M | 10.3M | 1.23M |
| Working Capital Changes | -16.94M | 4.68M | 4.65M | -50.58M | -9.15M | -15.73M | -7.12M | 48.37M | -16.62M | -21.58M | 3.74M | 7.88M |
| Change in Receivables | -8.51M | -55K | 4.08M | 5.56M | -4.95M | -1.96M | 295K | 24.35M | 4.78M | -19.45M | -6.63M | -126K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.02M |
| Change in Payables | -2.55M | 575K | 2.68M | -3.85M | -1.88M | 4.12M | -123K | -1.4M | -1.9M | 4.06M | 1.41M | -857K |
| Cash from Investing | -45.26M | 18.7M | 39.99M | 2.58M | -16.26M | 87.49M | 147.29M | -80.38M | 64.11M | -23.51M | -114.02M | 66.16M |
| Capital Expenditures | -11K | -184K | -251K | -86K | -1.17M | -1.07M | -828K | -756K | -446K | -1.44M | -328K | -1.6M |
| CapEx % of Revenue | 0.08% | 1.58% | 2.59% | 0.13% | 6.75% | 7.21% | 9.72% | 2.94% | 3.43% | 1.27% | 1.94% | 15.41% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -67.76M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67.76M |
| Cash from Financing | 103.08M | -64K | 102K | -60K | 66K | -24K | 1.02M | 96.49M | -3.43M | -3.13M | -5.74M | 137.66M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.08M | -3.13M | -3.13M | -3.13M |
| Equity Issued (Net) | 103.23M | 3K | 127K | -60K | 246K | 0 | 0 | 96.53M | 1.03M | 0 | 954K | 1.05M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -60K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -160K | -67K | -25K | 0 | -180K | -24K | 1.02M | -37K | -374K | 0 | -3.57M | 139.74M |
| Net Change in Cash | 15.55M | -7.8M | 1.9M | -42.2M | -84.08M | 15.73M | 83.79M | 25.57M | -4.05M | -12.57M | -153.26M | 172.62M |
| Free Cash Flow | -42.27M | -26.62M | -38.44M | -44.81M | -69.06M | -72.81M | -65.34M | 8.7M | -65.19M | 12.63M | -33.83M | -32.8M |
| FCF Margin % | -291.06% | -228.55% | -396.57% | -70.3% | -396.9% | -491.63% | -766.95% | 33.84% | -501.13% | 11.11% | -199.89% | -315.01% |
| FCF Growth % | 38.79% | 63.44% | 41.17% | -615.12% | -5.94% | -676.41% | -93.15% | 126.52% | -5.25% | 146.38% | -151.95% | -508.97% |
| FCF per Share | -3.23 | -3.10 | -4.53 | -5.30 | -8.31 | -8.82 | -7.96 | 1.07 | -10.61 | 2.07 | -5.58 | -5.44 |
| FCF Conversion (FCF/Net Income) | 1.10x | 0.57x | 0.67x | 3.89x | 0.89x | 0.99x | 1.32x | -0.20x | 1.11x | 0.45x | 0.68x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 247K | 0 | 0 | 0 | 155K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 4K | 7K | 2.35M | 2K | 15.15M | 0 | 0 | 0 | 0 |